A novel immune evasion strategy of KSHV K3 and K5
KSHV K3 和 K5 的新型免疫逃避策略
基本信息
- 批准号:6515143
- 负责人:
- 金额:$ 28.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-08 至 2006-04-30
- 项目状态:已结题
- 来源:
- 关键词:Callithricidae Herpesvirus saimiri Kaposi's sarcoma MHC class I antigen Saimiri cell adhesion molecules clinical research cytotoxic T lymphocyte host organism interaction human herpesvirus 8 human subject lymphoma membrane proteins microorganism immunology natural killer cells polymerase chain reaction protein structure function recombinant virus site directed mutagenesis viral carcinogenesis virus genetics virus protein virus virus interaction
项目摘要
DESCRIPTION (Provided by the applicant): Host immune responses including
cytoxic T lymphocytes (CTLs) and Natural killer (NK) cells play a role in the
elimination of virus-infected cells. To avoid these immune responses,
herpesviruses have evolved elaborate mechanisms that target and modulate
different aspects of the host's immune system. The proposed research is
directed toward investigating a novel immune evasion strategy employed by KSHV
K3 and K5 proteins. We have shown that both K3 and K5 membrane proteins
downregulate MHC class I molecules and that K5 additionally downregulates B7-2
and ICAM-1. We hypothesis that KSHV uses two genes similar but distinct
activities to ensure comprehensive protection from host immune effectors.
Specifically, K3 plays a major role in the inhibition of CTL lysis whereas K5
is primarily involved in suppression of NK cell-mediated cytotoxicity and T
helper (Th) cell-mediated immune response. In this proposal, we will draw upon
our experience in the biochemical analysis of viral gene function and in the
development and utilization of nonhuman primate models to define the detailed
mechanisms of immune evasion of K3 and K5. Our biochemical and immunological
studies will define in greater detail the mechanisms used by K3 and K5 to
inhibit CTL lysis, NK cell-mediated cytotoxicity, and Th cell-mediated immune
response. To define the role of K3 and K5 in viral immune evasion in vivo, we
will test whether K3 and K5 are capable of contributing to the establishment of
persistent infection of herpesvirus saimiri (HVS) in the natural host, squirrel
monkeys, and to the induction of lymphoma by HVS in the non-natural hosts,
common marmosets. Because of the lack of cell culture systems and animal models
for KSHV, this approach provides a unique opportunity to investigate the
contribution of the K3 and K5 genes to the escape of KSHV from hostile host
immune responses. The proposed studies will provide an understanding of a novel
immune evasion strategy of KSHV to survive destruction by host immune effector
cells and to achieve persistent infection.
描述(申请人提供):主机免疫反应,包括
细胞毒性T淋巴细胞(CTL)和天然杀伤(NK)细胞在
消除病毒感染的细胞。为了避免这些免疫反应,
疱疹病毒已经进化出了靶向和调节的精美机制
宿主免疫系统的不同方面。拟议的研究是
致力于研究KSHV采用的新型免疫逃避策略
K3和K5蛋白。我们已经表明K3和K5膜蛋白均
下调MHC I类分子,K5还下调了B7-2
和ICAM-1。我们假设KSHV使用两个基因相似但不同
确保宿主免疫效应子的全面保护的活动。
具体而言,K3在抑制CTL裂解中起主要作用,而K5
主要参与NK细胞介导的细胞毒性和T的抑制
助手(Th)细胞介导的免疫反应。在此提案中,我们将借鉴
我们在病毒基因功能的生化分析和
非人类灵长类动物模型的开发和利用来定义详细的
K3和K5免疫逃避的机制。我们的生化和免疫学
研究将更详细地定义K3和K5使用的机制
抑制CTL裂解,NK细胞介导的细胞毒性和TH细胞介导的免疫
回复。为了定义K3和K5在体内病毒免疫逃避中的作用,我们
将测试K3和K5是否有助于建立
天然宿主中的疱疹病毒Saimiri(HVS)的持续感染,松鼠
猴子,以及非天然宿主中HVS诱导淋巴瘤,
常见的果饼。由于缺乏细胞培养系统和动物模型
对于KSHV,这种方法提供了一个独特的机会来调查
K3和K5基因对KSHV从敌对主机逃脱的贡献
免疫反应。拟议的研究将提供对小说的理解
KSHV免疫逃避策略,以生存宿主免疫效应器的破坏
细胞并实现持续感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jae U Jung其他文献
Signaling Role of Viral Protein Motif and Its Application in CAR T Cell Therapy
- DOI:
10.1182/blood-2023-186305 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Kunho Chung;Wooram Jung;Jae U Jung;J. Joseph Melenhorst - 通讯作者:
J. Joseph Melenhorst
Jae U Jung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jae U Jung', 18)}}的其他基金
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
近期流行病期间妊娠期感染后婴儿的免疫和神经系统发育
- 批准号:
10784250 - 财政年份:2023
- 资助金额:
$ 28.57万 - 项目类别:
Reassortment of Bunyavirus in ticks and animal models
蜱和动物模型中布尼亚病毒的重排
- 批准号:
10512873 - 财政年份:2022
- 资助金额:
$ 28.57万 - 项目类别:
Reassortment of Bunyavirus in ticks and animal models
蜱和动物模型中布尼亚病毒的重排
- 批准号:
10686796 - 财政年份:2022
- 资助金额:
$ 28.57万 - 项目类别:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
KSHV G 蛋白偶联受体的结构分析和治疗性纳米抗体开发
- 批准号:
10413218 - 财政年份:2020
- 资助金额:
$ 28.57万 - 项目类别:
KSHVmediated regulation of proline metabolism
KSHV介导的脯氨酸代谢调节
- 批准号:
10293612 - 财政年份:2020
- 资助金额:
$ 28.57万 - 项目类别:
相似海外基金
A novel immune evasion strategy of KSHV K3 and K5
KSHV K3 和 K5 的新型免疫逃避策略
- 批准号:
6634065 - 财政年份:2001
- 资助金额:
$ 28.57万 - 项目类别:
A novel immune evasion strategy of KSHV K3 and K5
KSHV K3 和 K5 的新型免疫逃避策略
- 批准号:
6346753 - 财政年份:2001
- 资助金额:
$ 28.57万 - 项目类别: